PRGO — PERRIGO Co plc
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1585364 ·
Last close
$10.11
Market Cap
$1.40B
52W High
$12.26
52W Low
$9.40
ADV30
3,763,803
Next earnings
2026-08-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | — | — | — | — | — | — | — |
| Dec 2025 | 1,109,600,000 | 362,200,000 | 84,400,000 | -1,418,100,000 | 8,535,200,000 | 531,600,000 | 5,599,700,000 |
| Sep 2025 | 1,043,300,000 | 377,100,000 | 93,400,000 | 7,500,000 | 10,084,000,000 | 432,100,000 | 5,637,500,000 |
| Jun 2025 | 1,056,300,000 | 362,900,000 | 55,600,000 | -8,400,000 | 10,094,100,000 | 454,200,000 | 5,621,800,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$238,500,000
Investing CF
$-75,400,000
Financing CF
$-220,500,000
CapEx
$-93,400,000
Dividends Paid
$-159,300,000
Buybacks
—
EPS Diluted TTM
$-13.10
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-3,677,500,000
Inventory
$1,149,000,000
Receivables
$612,800,000
ST Investments
—
EBIT TTM
$-1,135,300,000
Pretax Income TTM
$-1,297,800,000
Interest Exp TTM
$162,500,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$4,178,400,000
EBITDA
$637,299,968
Free Cash Flow
$108,425,000
Enterprise Value
$4,870,397,952
Total Cash
$357,200,000
Total Debt
$3,828,699,904
Shares Out
138,367,770
Trailing EPS
$-12.93
Book Value
$18.09
ROE
-52.2%
ROA
2.1%
Div Yield
11.47%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 4,253,100,000 | 312,800,000 | -1,425,400,000 | 8,535,200,000 | 5,599,700,000 | — | 238,500,000 |
| Dec 2024 | 4,373,400,000 | 311,900,000 | -171,800,000 | 9,647,700,000 | 5,328,300,000 | — | 362,900,000 |
| Dec 2023 | 4,655,600,000 | 284,100,000 | -12,700,000 | 10,809,100,000 | 6,041,200,000 | — | 405,500,000 |
| Dec 2022 | 4,451,600,000 | 121,400,000 | -140,600,000 | 11,017,300,000 | 6,175,200,000 | — | 307,300,000 |
TTM Snapshot
Revenues TTM
$4,354,200,000
NetIncome TTM
$-115,100,000
OpCashFlow TTM
$0
Assets (Latest)
$9,647,700,000
Forward EPS
$2.37
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings, Inc. | $1.39B | $8.08 | — |
| AVBP | ArriVent BioPharma, Inc. | $1.39B | $29.82 | — |
| HROW | HARROW, INC. | $1.45B | $38.77 | — |
| XNCR | Xencor Inc | $1.50B | $20.21 | — |
| CMPS | COMPASS Pathways plc | $1.53B | $11.35 | — |
News headlines (Yahoo Finance, 1h cache)
Perrigo Announces Quarterly Dividend
2026-07-30 12:30 · Yahoo
Perrigo to Present at the Canaccord 46th Annual Growth Conference
2026-07-29 12:30 · Yahoo
Perrigo to Release Second Quarter 2026 Financial Results on August 5, 2026
2026-07-22 12:30 · Yahoo
Abbott (ABT) Q2 Earnings and Revenues Top Estimates
2026-07-16 12:40 · Yahoo
Perrigo Announces Appointment of Two New Independent Directors to Board
2026-06-30 20:25 · Yahoo
Stryker (SYK) Moves 5.3% Higher: Will This Strength Last?
2026-06-29 09:49 · Yahoo
FDA Seeks Updated Labeling for Testosterone Therapies
2026-06-18 21:56 · Yahoo
Jim Cramer on Perrigo Comapny: “This Is a Value Trap”
2026-06-17 16:53 · Yahoo
Perrigo Leadership Shakeup Puts Governance And Long Term Strategy In Focus
2026-06-09 04:32 · Yahoo
Perrigo Announces Leadership Transition
2026-06-08 20:18 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.